Skip to content
Riskpilot
← Back to search
Sign in
Get full access
ResoTher Pharma A/S
A/S
Active
Advertising protection
CVR 37852406
Dronninggårds Alle 136, 2840
Holte
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2016 · 9 years old
5 employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
ResoTher Pharma A/S
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Gross profit
DKK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
DKK millions
0M
-9M
-18M
-26M
-35M
-7M
2020
-12M
-71%
2021
-28M
-133%
2022
-18M
+36%
2023
-13M
+28%
2024
Income statement
DKK thousands
Item
2020
2021
2022
2023
2024
Gross profit
—
—
—
—
—
Staff expenses
-0
-0
-0
-0
-0
EBITDA
-7.084
-12.129
-28.066
-18.072
-12.825
Depreciation & amort.
-0
-588
4.343
-1.806
-0
EBIT
-7.084
-12.717
-32.409
-19.878
-12.825
Net financials
-497
-890
-309
-13
-12
Profit before tax
-7.581
-13.606
-32.718
-19.891
-12.837
Tax
-2.385
-1.928
-5.500
-2.393
-2.766
Net profit
-5.196
-11.678
-27.218
-17.498
-10.071
Balance sheet
DKK thousands
Item
2020
2021
2022
2023
2024
Total assets
4.535
41.406
18
21.761
14.847
Equity
-560
38.631
12.174
20.760
12.122
Long-term debt
3.677
0
0
0
0
Short-term debt
1.418
2.775
5.632
1.001
2.725
Total debt
5.095
2.775
5.632
1.001
2.725
Financial ratios
5-year trend
EBITDA margin (of gross profit)
-1282500000.0%
This company
2020
2024
Equity ratio
81.6%
This company
38.2%
Market median
+114% vs market
2020
2024
Return on equity
-83.1%
This company
18.4%
Market median
-552% vs market
2020
2024
Net profit margin (of gross profit)
-1007100000.0%
This company
2020
2024
Asset turnover (of gross profit)
0.00×
This company
2020
2024
Debt / equity
0.22×
This company
0.62×
Market median
+65% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via CVR / Virk · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via CVR / Virk · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via CVR / Virk · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via CVR / Virk · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via CVR / Virk · Period 2020-01-01 – 2020-12-31
View
PDF
More on ResoTher Pharma A/S
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
